Recruiting now—Ages 18 Years and up

REtroperitoneal SArcoma Registry: an International Prospective Initiative

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT03838718 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Retroperitoneal Sarcoma

Where it's running22 sites

University of Southern California (USC)
Los Angeles, California 90033
Recruiting now
- William Tseng, MD(contact)[email protected]
Mayo Clinic
Jacksonville, Florida 32224
Recruiting now
- Sanjay Bagaria, MD(contact)[email protected]
Moffitt Cancer Center
Tampa, Florida 33612
Recruiting now
- John Mullinax, MD(contact)[email protected]
Winship Cancer Institute
Emory, Georgia 30322
Recruiting now
- Kenneth Cardona, MD(contact)[email protected]
Brigham and Women's Hospital/Dana-Farber Cancer Institute
Boston, Massachusetts 02115
Recruiting now
- Chan Raut, MD(contact)[email protected]
The Ohio State University
Columbus, Ohio 43210
Recruiting now
- Raphael Pollock, MD(contact)[email protected]

16 international sites

Peter MacCallum Cancer Center
Melbourne, Australia
Recruiting now
- David Gyorki, MD(contact)[email protected]
Maisonneuve-Rosemont Hospital / University of Montreal
Montreal, Canada
Opening soon
- Mai-Kim Gervais, MD(contact)[email protected]
The Ottawa Hospital
Ottawa, Canada
Recruiting now
- Carolyn Nessim, MD(contact)[email protected]
Mount Sinai / Princess Margaret
Toronto, Canada
Recruiting now
- Carol Swallow, MD(contact)[email protected]
Institut Curie
Paris, France
Recruiting now
- Sylvie Bonvalot, MD(contact)[email protected]
University Medical Center and Medical Faculty Mannheim, University of Heidelberg
Mannheim, Germany
Opening soon
- Peter Hohenberger, MD(contact)[email protected]
Ludwig Maximilian University
Munich, Germany
Recruiting now
- Markus Albertsmeier, MD(contact)[email protected]
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy 20133
Recruiting now
- Alessandro Gronchi, MD(principal investigator)
- Marco Fiore, MD(sub investigator)
- Dario Callegaro, MD(sub investigator)
Veneto Institute of Oncology
Padova, Italy
Recruiting now
- Marco Rastrelli, MD(contact)[email protected]
Ospedale Borgo Roma
Verona, Italy
Recruiting now
- Tommaso Campagnaro, MD(contact)[email protected]
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
Warsaw, Poland
Recruiting now
- Piotr Rutkowski, MD(contact)[email protected]
Institute of Oncology Ljubljana
Ljubljana, Slovenia
Recruiting now
- Marko Novak, MD(contact)[email protected]
Samsung Medical Center
Seoul, South Korea
Opening soon
- Sung Jo Kim(contact)[email protected]
Hospital Clinico Universitario "Virgen de la Arrixaca"
Murcia, Spain
Opening soon
- Juan Angel Fernandez, MD(contact)[email protected]
University Hospital Birmingham (Queen Elizabeth)
Birmingham, United Kingdom
Recruiting now
- Samuel Ford, MD(contact)[email protected]
Royal Marsden Hospital
London, United Kingdom
Recruiting now
- Dirk Strauss, MD(contact)[email protected]

See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* primary RPS operated on in the participating center;
* age\>18 years at the time of the first treatment (pediatric patients can not be included)
* histological confirmed diagnosis according to the WHO criteria done on biopsy or surgical specimen by dedicated sarcoma pathologist;
* radiological examinations performed (contrast enhanced abdominal CT scan and/or MRI) prior to surgical resection;
* signed informed consent form;
* adequate compliance of the patients to the plan of follow-up

Exclusion Criteria:

* age\<18 years;
* recurrent tumor;
* benign retroperitoneal tumors;
* serious psychiatric disease that precludes informed consent or limits compliance;
* impossibility to ensure adequate follow-up

Updated 2019-02-12 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.